High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection.
暂无分享,去创建一个
Hui Zhu | Wei Yang | Kequan Li | Wen-zhi Chen | Lian Zhang | Wei Yang | Feng Wu | J. Bai | Hui Zhu | Zhibiao Wang | Kequan Li | C. Jin | Haibing Su | Feng Wu | Jin Bai | Kun Zhou | Zhibiao Wang | Lian Zhang | Song Peng | Chengbin Jin | Haibing Su | Wenzhi Chen | K. Zhou | Song Peng
[1] P. McCormack,et al. Use of prosthetic materials in chest-wall reconstruction. Assets and liabilities. , 1989, The Surgical clinics of North America.
[2] Ian Rivens,et al. The use of a segmented transducer for rib sparing in HIFU treatments. , 2006, Ultrasound in medicine & biology.
[3] John Wong,et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.
[4] A. E. Miller,et al. A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY , 1942, The Journal of general physiology.
[5] J. Pignon,et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. , 1998, Journal of hepatology.
[6] Wen-Zhi Chen,et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. , 2004, Ultrasonics sonochemistry.
[7] D. Chan,et al. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] T. Livraghi,et al. Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia. , 1993, AJR. American journal of roentgenology.
[9] Diagnosis and treatment of hepatocellular carcinoma , 1997 .
[10] Win-Li Lin,et al. Feasibility of transrib focused ultrasound thermal ablation for liver tumors using a spherically curved 2D array: a numerical study. , 2007, Medical physics.
[11] P. Dartevelle,et al. Radical resection of radiation-induced sarcoma of the chest wall: report of 15 cases. , 1997, The Annals of thoracic surgery.
[12] Wen-zhi Chen,et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. , 2004, Ultrasound in medicine & biology.
[13] M. Uetani,et al. Percutaneous Radiofrequency Ablation and Transcatheter Arterial Chemoembolization for Hypervascular Hepatocellular Carcinoma: Rate and Risk Factors for Local Recurrence , 2007, CardioVascular and Interventional Radiology.
[14] Kenji Ikeda,et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model , 1991, Cancer.
[15] Elizabeth A Stewart,et al. Magnetic Resonance-Guided Focused Ultrasound Surgery , 2010, Seminars in reproductive medicine.
[16] M. Makuuchi,et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. , 2006, Gastroenterology.
[17] Wen-Zhi Chen,et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. , 2005, Radiology.
[18] J. Bruix,et al. Chemoembolization for hepatocellular carcinoma. , 2004, Gastroenterology.
[19] R. Sanders,et al. Subclavian vein obstruction without thrombosis. , 2005, Journal of vascular surgery.
[20] D. Kopelman,et al. Magnetic resonance guided focused ultrasound surgery. Ablation of soft tissue at bone–muscle interface in a porcine model , 2008, European journal of clinical investigation.
[21] J. Bruix,et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution , 1998, Hepatology.
[22] Ramon Planas,et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.
[23] W J FRY,et al. Production of focal destructive lesions in the central nervous system with ultrasound. , 1954, Journal of neurosurgery.
[24] K. Hynynen,et al. Trans-skull ultrasound therapy: the feasibility of using image-derived skull thickness information to correct the phase distortion , 1999, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[25] M. Sakuraba,et al. Surgical treatment of tuberculous abscess in the chest wall. , 2005, The Annals of thoracic surgery.
[26] K. Hayashi,et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation , 2003, Journal of Gastroenterology.
[27] G. Gandini,et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC) , 2006, European Radiology.